Certain 9/11 First Responders & Survivors Are Eligible for Skin Cancer Treatment At No Cost

BURR RIDGE, Ill., Sept. 10, 2025 /PRNewswire/ -- As the nation commemorates the tragic events of 9/11, SkinCure Oncology, the industry leader in providing a comprehensive cancer center model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for the treatment of nonmelanoma skin cancer (NMSC), presented to dermatology patients and professionals as the GentleCure Experience™, reminds that day's survivors and first responders that if they are diagnosed with nonmelanoma skin cancer, nonsurgical treatment by select dermatologists is fully covered for most by a special government program.

The federal World Trade Center (WTC) Health Program provides high-quality, compassionate medical monitoring and treatment for WTC-related conditions to those directly affected by the September 11^th, 2001, attacks in New York, at the Pentagon, and in Shanksville, Pennsylvania.

SkinCure Oncology Chief Executive Officer Kerwin Brandt notes, "Melanoma and nonmelanoma skin cancers are among the top 10 most common 9/11-related cancers reported among those present in the aftermath of the 9/11 attacks. The WTC Health Program recognizes this and may cover your cost of care. If you were a first responder or otherwise directly affected by the 9/11 events and have been diagnosed with skin cancer, you need to know about your treatment options. Visit GentleCure.com or call the GentleCure Hotline (855-618-1752) to learn more about a noninvasive skin cancer treatment."

For more information about the WTC Health Program, visit cdc.gov/wtc.

About SkinCure Oncology

SkinCure Oncology is the industry leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT), the most advanced nonsurgical treatment for common skin cancer. The company partners with quality-focused dermatologists, Mohs surgeons and other physicians to bring cancer center-level radiation therapy treatment to private practices. Presented to patients as the GentleCure Experience™, Image-Guided SRT is available from some 500 physicians nationwide, with well more than 100,000 patients having been treated. Learn more about the company at SkinCureOncology.com, and visit GentleCure.com for helpful consumer and patient information.

Media Contact:
Matt Russell
Russell Public Communications
520-232-9840
[email protected] 

SOURCE SkinCure Oncology